Christopher Couch1, Tim Franxman2, Matthew Greenhawt3. 1. Division of Allergy and Clinical Immunology, The University of Michigan Medical School, Ann Arbor, Michigan; Allergy Asthma Clinic, Ltd, Phoenix, Arizona. 2. Family Allergy and Asthma Center, Florence, Kentucky. 3. Division of Allergy and Clinical Immunology, The University of Michigan Medical School, Ann Arbor, Michigan; The Child Health Evaluation and Research Unit, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan; Section of Allergy, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: mgreenhawt@gmail.com.
Abstract
BACKGROUND: Characteristics and outcomes of tree nut (TN) oral food challenges (OFCs) in patients with TN allergy or sensitization alone are poorly studied. OBJECTIVE: To determine the relation between TN sensitization levels and OFC outcomes. METHODS: Open TN OFCs performed from 2007 through 2015 at a referral center were analyzed to compare outcome based on skin prick test (SPT) wheal size, food-specific immunoglobulin E (sIgE), peanut co-allergy, and TN sensitization only vs TN allergy with sensitization to other TNs. Delayed OFC was defined as longer than 12 months from the time of an sIgE level lower than 2 kUA/L. RESULTS: Overall passage rate was 86% for 156 TN OFCs in 109 patients (54 almond, 28 cashew, 27 walnut, 18 hazelnut, 14 pecan, 13 pistachio, and 2 Brazil nut). Passage rates were 76% (n = 67) in patients with a history of TN allergy who were challenged to another TN to which they were sensitized and 91% (n = 65) in those with TN sensitization only (mean sIgE 1.53 kUA/L; range 0.35-9.14). Passage rates were 89% (n = 110 of 124) for a TN sIgE level lower than 2 kUA/L and 69% (11 of 16) for a TN sIgE level of at least 2 kUA/L. In 44 challenges in patients with peanut allergy and TN co-sensitization, the TN OFC passage rate was 96%. In 41 TN OFCs with a TN SPT wheal size of at least 3 mm, 61% passed, with a mean wheal size of 4.8 mm (range 3-11) in those passing vs 9 mm (range 3-20) in those failing. CONCLUSION: TN challenges are frequently passed in patients with TN sensitization with or without a history of TN reactivity despite a TN SPT wheal of at least 3 mm or a TN sIgE level of at least 2 kUA/L. Nearly all patients with peanut allergy and TN co-sensitization passed the TN challenge, questioning the clinical relevance of "co-allergy."
BACKGROUND: Characteristics and outcomes of tree nut (TN) oral food challenges (OFCs) in patients with TN allergy or sensitization alone are poorly studied. OBJECTIVE: To determine the relation between TN sensitization levels and OFC outcomes. METHODS: Open TN OFCs performed from 2007 through 2015 at a referral center were analyzed to compare outcome based on skin prick test (SPT) wheal size, food-specific immunoglobulin E (sIgE), peanut co-allergy, and TN sensitization only vs TN allergy with sensitization to other TNs. Delayed OFC was defined as longer than 12 months from the time of an sIgE level lower than 2 kUA/L. RESULTS: Overall passage rate was 86% for 156 TN OFCs in 109 patients (54 almond, 28 cashew, 27 walnut, 18 hazelnut, 14 pecan, 13 pistachio, and 2 Brazil nut). Passage rates were 76% (n = 67) in patients with a history of TN allergy who were challenged to another TN to which they were sensitized and 91% (n = 65) in those with TN sensitization only (mean sIgE 1.53 kUA/L; range 0.35-9.14). Passage rates were 89% (n = 110 of 124) for a TN sIgE level lower than 2 kUA/L and 69% (11 of 16) for a TN sIgE level of at least 2 kUA/L. In 44 challenges in patients with peanutallergy and TN co-sensitization, the TN OFC passage rate was 96%. In 41 TN OFCs with a TN SPT wheal size of at least 3 mm, 61% passed, with a mean wheal size of 4.8 mm (range 3-11) in those passing vs 9 mm (range 3-20) in those failing. CONCLUSION:TN challenges are frequently passed in patients with TN sensitization with or without a history of TN reactivity despite a TN SPT wheal of at least 3 mm or a TN sIgE level of at least 2 kUA/L. Nearly all patients with peanutallergy and TN co-sensitization passed the TN challenge, questioning the clinical relevance of "co-allergy."
Authors: David M Fleischer; S Allan Bock; Gayle C Spears; Carla G Wilson; Naomi K Miyazawa; Melanie C Gleason; Elizabeth A Gyorkos; James R Murphy; Dan Atkins; Donald Y M Leung Journal: J Pediatr Date: 2010-10-28 Impact factor: 4.406
Authors: David M Fleischer; Mary Kay Conover-Walker; Elizabeth C Matsui; Robert A Wood Journal: J Allergy Clin Immunol Date: 2005-10-10 Impact factor: 10.793
Authors: Ruchi S Gupta; Elizabeth E Springston; Manoj R Warrier; Bridget Smith; Rajesh Kumar; Jacqueline Pongracic; Jane L Holl Journal: Pediatrics Date: 2011-06-20 Impact factor: 7.124
Authors: Tamara T Perry; Elizabeth C Matsui; Mary Kay Conover-Walker; Robert A Wood Journal: J Allergy Clin Immunol Date: 2004-07 Impact factor: 10.793
Authors: Hugh A Sampson; Seema Aceves; S Allan Bock; John James; Stacie Jones; David Lang; Kari Nadeau; Anna Nowak-Wegrzyn; John Oppenheimer; Tamara T Perry; Christopher Randolph; Scott H Sicherer; Ronald A Simon; Brian P Vickery; Robert Wood; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Jay Portnoy; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace; Hugh A Sampson; Seema Aceves; S Allan Bock; John James; Stacie Jones; David Lang; Kari Nadeau; Anna Nowak-Wegrzyn; John Oppenheimer; Tamara T Perry; Christopher Randolph; Scott H Sicherer; Ronald A Simon; Brian P Vickery; Robert Wood Journal: J Allergy Clin Immunol Date: 2014-08-28 Impact factor: 10.793
Authors: Jennifer M Maloney; Magnus Rudengren; Staffan Ahlstedt; S A Bock; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2008-05-27 Impact factor: 10.793
Authors: Yamini V Virkud; Yih-Chieh Chen; Elisabeth S Stieb; Alexandra R Alejos; Nicholas Renton; Wayne G Shreffler; Paul E Hesterberg Journal: J Allergy Clin Immunol Pract Date: 2019-04-08